How ReWalk’s $19M acquisition could help it turn a profit after 22 years

At 22 years old, the Marlborough-based maker of so-called personal exoskeletons to help people who’ve lost mobility is finally nearing a long-awaited inflection point: becoming profitable. The company will spend $19 million to acquire AlterG, a Fremont, California-based company behind bionic legs and "anti-gravity" physical rehabilitation systems. Part of the goal in acquiring AlterG is…

Read More

Flagship-backed RNA startup company raises $109M

Nearly two years after launching, a big RNA play from venture firm Flagship Pioneering has announced a nine-figure raise. Alltrna, the startup behind still-experimental drugs that use transfer RNA or "tRNA," raised $109 million in a Series B round. But the company isn’t naming any investors, aside from Flagship, alluding only to "a number of…

Read More